UBS Group’s ETRACS Quarterly Pay 1.5x Leveraged Alerian MLP Index ETN MLPR Stock Holding History

UBS Group’s Portfolio MLPR Stock Details MLPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-55,460	Closed	-$3.24M	–	10918
2025 Q4	$3.24M	Buy	+55,460	New	+$3.16M	﹤0.01%	4477
2025 Q2	–	Sell	-30	Closed	-$2.05K	–	10625
2025 Q1	$2.05K	Buy	+30	New	+$1.98K	﹤0.01%	9405
2024 Q4	–	Sell	-147	Closed	-$8.46K	–	10225
2024 Q3	$8.46K	Buy	+147	New	+$8.44K	﹤0.01%	7837
2023 Q1	–	Sell	-90	Closed	-$3.71K	–	10056
2022 Q4	$3.71K	Sell	90 -301	-77%	-$12.5K	﹤0.01%	9464
2022 Q3	$15K	Hold	391	–	–	﹤0.01%	7812
2022 Q2	$13K	Buy	+391	New	+$15.5K	﹤0.01%	7522

Other funds holding MLPR

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return

UBS Group's MLPR Position: Q1 2026 in Review

UBS Group sold out of ETRACS Quarterly Pay 1.5x Leveraged Alerian MLP Index ETN (MLPR) in Q1 2026, closing a stake of 55,460 shares — an estimated $3.24M sold.

UBS Group first reported a position in MLPR in Q2 2022 and held it in 6 quarters. The position peaked at $3.24M in Q4 2025. 2 funds tracked by Wall St. Rank hold MLPR as of Q1 2026.

UBS Group reported no remaining ETRACS Quarterly Pay 1.5x Leveraged Alerian MLP Index ETN position as of Q1 2026 after selling out during the quarter.
UBS Group sold 55,460 ETRACS Quarterly Pay 1.5x Leveraged Alerian MLP Index ETN shares in Q1 2026, an estimated $3.24M.
UBS Group first reported a position in ETRACS Quarterly Pay 1.5x Leveraged Alerian MLP Index ETN in Q2 2022 and held it in 6 quarters.
UBS Group's ETRACS Quarterly Pay 1.5x Leveraged Alerian MLP Index ETN position peaked at $3.24M in Q4 2025.
2 funds tracked by Wall St. Rank held ETRACS Quarterly Pay 1.5x Leveraged Alerian MLP Index ETN as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.